News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
296,707 Results
Type
Article (15750)
Company Profile (261)
Press Release (280689)
Multimedia
Podcasts (127)
Webinars (13)
Section
Business (90824)
Career Advice (170)
Deals (13525)
Drug Delivery (69)
Drug Development (51101)
Employer Resources (32)
FDA (6009)
Job Trends (5224)
News (145931)
Policy (10090)
Tag
2025 Best Places to Work (13)
2026 Best Places to Work (19)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (1)
2027 Genetown Standard (4)
2027 Pharm Country Standard (3)
40 Under 40 (4)
Academia (978)
Accelerated approval (39)
ADA (34)
Adcomms (16)
Allergies (128)
Alliances (21770)
ALS (204)
Alzheimer's disease (1263)
Antibody-drug conjugate (ADC) (582)
Approvals (6441)
Artificial intelligence (491)
ASCO (224)
Autoimmune disease (410)
Automation (20)
Bankruptcy (112)
Belgium (29)
Best Places to Work (4559)
BIO (56)
Biologics (71)
BIOSECURE Act (6)
Biosimilars (161)
BioSpace Insights (81)
Biotechnology (179)
Bispecific (53)
Bladder cancer (143)
Brain cancer (73)
Breast cancer (510)
Cancer (5044)
Cardiovascular disease (375)
Career advice (174)
Career pathing (15)
CAR-T (347)
CDC (11)
CDMO (127)
Celiac Disease (6)
Cell therapy (888)
Cervical cancer (31)
Clinical research (46640)
Collaboration (1779)
Commercialization (44)
Company closure (4)
Compensation (987)
Complete response letters (73)
COVID-19 (1156)
CRISPR (131)
CRO (4)
C-suite (1057)
Cystic fibrosis (132)
Data (7636)
Denatured (27)
Depression (134)
Dermatology (131)
Diabetes (404)
Diagnostics (1562)
Digital health (21)
Diversity (6)
Diversity, equity & inclusion (9)
Drug discovery (360)
Drug pricing (55)
Drug shortages (4)
Duchenne muscular dystrophy (343)
Earnings (33923)
Editorial (37)
Employer branding (4)
Employer resources (30)
ESMO (311)
Events (55580)
Executive appointments (804)
Eye disease (16)
FDA (8825)
Fibrodysplasia Ossificans Progressiva (11)
Fragile X (6)
Friedreich's ataxia (28)
Frontotemporal dementia (36)
Funding (1495)
Gene editing (264)
Generative AI (50)
Gene therapy (725)
GLP-1 (638)
Government (1217)
Grass and pollen (3)
Guidances (182)
Healthcare (6832)
Hematology (143)
HIV (40)
Huntington's disease (75)
Idiopathic pulmonary fibrosis (10)
IgA nephropathy (125)
Immunology and inflammation (291)
Immuno-oncology (122)
Indications (191)
Infectious disease (1338)
Inflammatory bowel disease (216)
Inflation Reduction Act (10)
Influenza (64)
Intellectual property (262)
Interviews (21)
IPO (7422)
IRA (13)
Job creations (871)
Job search strategy (139)
JPM (41)
Kidney cancer (13)
Kidney disease (125)
Labor market (46)
Layoffs (280)
Leadership (22)
Legal (1406)
Licensing (99)
Liver cancer (54)
Longevity (39)
Lung cancer (700)
Lung diease (19)
Lymphoma (369)
Machine learning (37)
Management (8)
Manufacturing (712)
Marketing (25)
MASH (189)
Medical affairs (4)
Medical device (2759)
Medtech (2814)
Melanoma (110)
Mergers & acquisitions (6989)
Metabolic disorders (1117)
Middle East (1)
mRNA (230)
Multiple sclerosis (162)
Multispecific (6)
NASH (14)
Netherlands (19)
Neurodegenerative disease (433)
Neuropsychiatric disorders (105)
Neuroscience (2778)
Neurotech (2)
NextGen: Class of 2026 (2040)
Non-profit (891)
Now hiring (50)
Obesity (496)
Opinion (161)
Ovarian cancer (232)
Pain (174)
Pancreatic cancer (310)
Parkinson's disease (366)
Partnered (19)
Patents (512)
Patient advocacy (7)
Patient recruitment (682)
Patient selection (93)
Peanut (55)
People (27975)
Peptides (33)
Pharmaceutical (31)
Pharmacy benefit managers (9)
Phase 1 (16514)
Phase 2 (21706)
Phase 3 (13729)
Pipeline (9235)
Policy (114)
Postmarket research (853)
Preclinical (6977)
Press Release (30)
Prostate cancer (247)
Psychedelics (89)
Radioligand (3)
Radiopharmaceuticals (342)
Rare diseases (1132)
Real estate (1461)
Recruiting (12)
Regenerative medicine (24)
Regulatory (11458)
Reports (33)
Research institute (1008)
Resumes & cover letters (20)
Rett syndrome (51)
RNA editing (38)
RSV (26)
Schizophrenia (175)
Series A (295)
Series B (198)
Series C (1)
Service/supplier (1)
Sickle cell disease (110)
Special edition (24)
Spinal muscular atrophy (131)
Sponsored (22)
Startups (2057)
State (1)
Stem cells (7)
Stomach cancer (7)
Substance use disorders (20)
Supply chain (49)
Switzerland (14)
Tariffs (20)
The Weekly (98)
Vaccines (472)
Venture capital (120)
Weight loss (263)
Wet AMD (6)
Women's health (63)
Women in leadership (1)
Worklife (4)
Date
Today (69)
Last 7 days (443)
Last 30 days (2261)
Last 365 days (18523)
2026 (16902)
2025 (18094)
2024 (20467)
2023 (22412)
2022 (26810)
2021 (27802)
2020 (23355)
2019 (16222)
2018 (11735)
2017 (13743)
2016 (11838)
2015 (14348)
2014 (10392)
2013 (7483)
2012 (7532)
2011 (7614)
2010 (7429)
Location
Africa (160)
Alabama (86)
Alaska (2)
Arizona (108)
Arkansas (6)
Asia (19314)
Australia (3328)
California (10479)
Canada (2597)
China (1381)
Colorado (397)
Connecticut (395)
Delaware (364)
Europe (41377)
Florida (1380)
Georgia (289)
Hawaii (3)
Idaho (18)
Illinois (656)
India (78)
Indiana (246)
Iowa (13)
Japan (408)
Kansas (93)
Kentucky (13)
Louisiana (18)
Maine (14)
Maryland (1071)
Massachusetts (8369)
Michigan (143)
Minnesota (362)
Mississippi (4)
Missouri (41)
Montana (17)
Nebraska (6)
Nevada (71)
New Hampshire (22)
New Jersey (2357)
New Mexico (14)
New York (2545)
North Carolina (1212)
North Dakota (9)
Northern California (5447)
Ohio (254)
Oklahoma (12)
Oregon (28)
Pennsylvania (1898)
Puerto Rico (12)
Rhode Island (31)
South America (217)
South Carolina (20)
Southern California (4255)
Tennessee (72)
Texas (1505)
United States (34537)
Utah (145)
Virginia (212)
Washington D.C. (37)
Washington State (850)
West Virginia (1)
Wisconsin (81)
Wyoming (1)
296,707 Results for "monopar therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Monopar Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates
November 12, 2026
·
7 min read
Press Releases
Monopar Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
August 12, 2026
·
9 min read
Press Releases
Monopar to Present at AASLD – The Liver Meeting® 2026: Phase 3 FoCus Baseline Data and ALXN1840 Molybdenum Safety Data
November 2, 2026
·
4 min read
Press Releases
Monopar Presents Data Highlighting Residual Disease Burden in Treatment-Experienced Wilson Disease Patients and Long-Term Molybdenum Safety Data for ALXN1840 at AASLD – The Liver Meeting® 2026
November 9, 2026
·
5 min read
Press Releases
Monopar Therapeutics Receives FDA Rare Pediatric Disease Designation for ALXN1840 for the Treatment of Wilson Disease
June 30, 2026
·
5 min read
Press Releases
Monopar Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates
May 14, 2026
·
6 min read
Press Releases
Monopar Initiates Rolling NDA Submission for ALXN1840 in Wilson Disease
July 22, 2026
·
5 min read
Press Releases
Monopar Appoints Jeffrey D. Kent, M.D., as Executive Vice President, Head of Medical Affairs; Announces Two ALXN1840 Presentations at AASLD – The Liver Meeting® 2026
August 19, 2026
·
7 min read
Press Releases
Monopar Advances Launch Readiness with Addition of Veteran Commercial Executive Nicole Sweeny to Board of Directors and Expansion of Commercial Leadership Team
July 20, 2026
·
5 min read
Press Releases
Rosalind Franklin University’s Helix 51 Incubator Welcomes Monopar Therapeutics
Monopar’s pipeline includes clinical-stage radiopharmaceuticals targeting advanced solid tumors and late-stage ALXN1840, a treatment for Wilson Disease
January 23, 2025
·
1 min read
1 of 29,671
Next